PatentsUSA
Supreme Court Sides with Hikma in Patent Dispute Against Amarin
The U.S. Supreme Court has ruled in favor of Hikma Pharmaceuticals in a patent infringement case brought by Amarin. This ruling resolves a significant dispute over patent rights and market competition between the two pharmaceutical companies.
Thursday, June 4, 2026